A stakeholder meeting was held on 24 June 2014 to discuss the PBS listing of eculizumab (Soliris) for atypical haemolytic uraemic syndrome.

There was constructive discussion that worked towards finalising the prescribing criteria for listing the product on the PBS consistent with the March 2014 recommendation by the PBAC under a Managed Entry Scheme.

For more details, go to: http://www.pbs.gov.au/info/news/2014/09/pbs-listing-of-eculizumab